Hong Kong stocks surge | Beiwo Pharmaceuticals-B (02142.HK) rises more than 5% and reaches a strategic cooperation with Evinova to build an AI-driven open ecosystem for drug research and development.

According to the Wise News Finance APP, H&P Medicine-B (02142.HK) has risen by more than 5%, as of the time of publication, it has increased by 5.46%, to 13.94 Hong Kong dollars, with a trading volume of 17,196.9 million Hong Kong dollars.